We congratulate Professsor Hongyu Zhang, local PI in the First Hospital affiliated to Chongqing Medical University (FHA-CQMU) on joining the COLOR III trial.

In China mainland there are currently 6 sites open for inclusion of patients in the global RCT. With Sun Yat-sen Cancer Center Taipei and Queen Mary hospital HongKong and soon sites from Japan, Korea and Singapore Asia is contributing significantly to COLOR III!